Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vericel Corp Ord
VCELCurrent price
40.92 USD
+0.4 USD (+0.99%)
Last closed
41.38 USD
Company
vcel.com
ISIN
US92346J1088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 083 193 344 USD
Yield for 12 month
-14.70 %
1Y
3Y
5Y
10Y
15Y
VCEL
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Address: 64 Sidney Street, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
59.38 USDP/E ratio
827.60Dividend Yield
–Current Year
+237 224 000 USD
Last Year
+197 516 000 USD
Current Quarter
+52 598 000 USD
Last Quarter
+75 376 000 USD
Current Year
+172 107 000 USD
Last Year
+135 576 000 USD
Current Quarter
+36 273 000 USD
Last Quarter
+58 499 000 USD
Key Figures VCEL
1 year
3 years
5 years
10 years
EBITDA
4 003 000 USD
Operating Margin TTM
Price to Earnings
827.60
Return On Assets TTM
-0.45 %
PEG Ratio
–
Return On Equity TTM
1.13 %
Wall Street Target Price
59.38 USD
Revenue TTM
238 540 992 USD
Book Value
5.88 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2.60 %
Dividend Yield
–
Gross Profit TTM
173 026 000 USD
Earnings per share
0.050 USD
Diluted Eps TTM
0.050 USD
Most Recent Quarter
I 2025
Quarterly Earnings Growth YOY
47.60 %
Profit Margin
1.25 %
Dividend Analytics VCEL
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History VCEL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:20
Payout Ratio TTM
–
Last Split Date
16.10.2013
Stock Valuation VCEL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
827.60
Forward PE
151.52
Enterprise Value Revenue
8.67
Price Sales TTM
8.73
Enterprise Value EBITDA
196.10
Price Book MRQ
7.05
Financials VCEL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VCEL
For 52 weeks
37.39 USD
63.00 USD
50 Day MA
42.48 USD
Shares Short Prior Month
4 490 945
200 Day MA
49.03 USD
Short Ratio
8.50
Shares Short
4 622 469
Short Percent
11.94 %
BeatStart